Although it is often marketed alongside peptides, 5-Amino-1MQ is not technically a peptide
Importantly, AOD-9604 did not produce any of the adverse effects associated with growth hormone therapy, including glucose intolerance, insulin resistance, edema, joint pain, or tissue growth abnormalities
For further information on proper storage techniques, click the link below: Peptide Storage Information 5-Amino-1MQ is studied in experimental research related to metabolic enzyme pathways and cellular metabolism
Delivery times may vary depending on the shipping destination, carrier delays, and order processing times
It was developed in the 1990s by researchers at Monash University in Melbourne, Australia, with one goal: isolate the fat-burning portion of growth hormone and deliver those effects without the risks that come with full hGH administration